Completed
CISPLATIN + AZD-1775 In Breast Cancer
NCT03012477
- Conditions
- Triple-negative Metastatic Breast Cancer
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Triple-negative Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.
NCT03012477